Aliza K. Fink
Eli Lilly (United States)(US)American Society of Hematology(US)Loxo Oncology at Lilly (United States)(US)Statistics Collaborative(US)National Organization for Rare Disorders(US)
Publications by Year
Research Areas
Cystic Fibrosis Research Advances, Tracheal and airway disorders, Advanced Causal Inference Techniques, Neonatal Respiratory Health Research, Global Cancer Incidence and Screening
Most-Cited Works
- → Applying Quantitative Bias Analysis to Epidemiologic Data(2009)544 cited
- → The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry(2016)472 cited
- → Adherence to tamoxifen over the five-year course(2006)319 cited
- → Patient Beliefs and Tamoxifen Discontinuance in Older Women With Estrogen Receptor—Positive Breast Cancer(2004)284 cited
- → Semi-Automated Sensitivity Analysis to Assess Systematic Errors in Observational Data(2003)253 cited
- → Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis(2015)232 cited